Science Explorer Interactive view Map
Company · Gaithersburg · United States

Codex Biosolutions (United States)

codexbiosolutions.comROR OpenAlex
Research works
11
▲ 794% vs 2013–17
Citations
463
41.9 per fractional work
Top-10% rate
22.1%
record average 16.5%
Open access
59%
world 28%

Not ranked overall: Codex Biosolutions (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.93× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.84× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 4.30× its world share, 0 worksImmunology and Micro…Neuroscience: 2.14× its world share, 0 worksNeuroscienceEngineering: 0.24× its world share, 0 worksEngineeringEnvironmental Science: 0.21× its world share, 0 worksEnvironmental ScienceMedicine: 3.26× its world share, 2 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.3×. Every wedge is a field page.

Which research topics does Codex Biosolutions (United States) publish most on?

By volume in 2022–2025: SARS-CoV-2 and COVID-19 Research, Viral Infectious Diseases and Gene Expression in Insects, CAR-T cell therapy research and COVID-19 Clinical Research Studies.

SARS-CoV-2 and COVID-19 …0SARS-CoV-2 and COVID-19 Research: 0 fractional worksViral Infectious Disease…0Viral Infectious Diseases and Gene Expression in Insects: 0 fractional worksCAR-T cell therapy research: 0 fractional worksCOVID-19 Clinical Research Studies: 0 fractional worksSARS-CoV-2 detection and testing: 0 fractional worksMultiple Myeloma Research and Treatments: 0 fractional worksMonoclonal and Polyclona…0Monoclonal and Polyclonal Antibodies Research: 0 fractional worksProtein purification and stability: 0 fractional worksAnimal Virus Infections Studies: 0 fractional worksCholinesterase and Neurodegenerative Diseases: 0 fractional works
Infectious DiseasesMolecular BiologyOncologyHematology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  2. 2 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
  3. 3 CAR-T cell therapy research Oncology 0 works
  4. 4 COVID-19 Clinical Research Studies Infectious Diseases 0 works
  5. 5 SARS-CoV-2 detection and testing Infectious Diseases 0 works
  6. 6 Multiple Myeloma Research and Treatments Hematology 0 works
  7. 7 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  8. 8 Protein purification and stability Molecular Biology 0 works
  9. 9 Animal Virus Infections Studies Animal Science and Zoology 0 works
  10. 10 Cholinesterase and Neurodegenerative Diseases Pharmacology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available59.3%not open40.7%

World: 28% of research is openly available.

with international co-authors23.8%domestic only76.2%

World: 19% is written across borders.

How has Codex Biosolutions (United States)'s research output changed?

Output in 2018–2022 was 794% higher than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Gaithersburg

All research institutions in Gaithersburg

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.